TD ASSET MANAGEMENT INC - PROGENICS PHARMACEUTICALS IN ownership

PROGENICS PHARMACEUTICALS IN's ticker is PGNX and the CUSIP is 743187106. A total of 131 filers reported holding PROGENICS PHARMACEUTICALS IN in Q1 2020. The put-call ratio across all filers is 0.49 and the average weighting 0.0%.

Quarter-by-quarter ownership
TD ASSET MANAGEMENT INC ownership history of PROGENICS PHARMACEUTICALS IN
ValueSharesWeighting
Q1 2020$257,000
-48.0%
67,500
-30.4%
0.00%
-100.0%
Q4 2019$494,000
-5.9%
97,000
-6.6%
0.00%0.0%
Q3 2019$525,000
+100.4%
103,800
+144.6%
0.00%
Q2 2019$262,00042,4300.00%
Other shareholders
PROGENICS PHARMACEUTICALS IN shareholders Q1 2020
NameSharesValueWeighting ↓
EVERENCE CAPITAL MANAGEMENT INC 28,980$123,0000.01%
Daiwa Securities Group Inc. 533$2,0000.00%
IFP Advisors, Inc 0$00.00%
NEW YORK STATE TEACHERS RETIREMENT SYSTEM 138,663$52,0000.00%
View complete list of PROGENICS PHARMACEUTICALS IN shareholders